Streetbeat News

Regulatory

CTXR

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) has announced reaching a significant milestone in its Phase 3 clinical trial for Mino-Lok, an antibiotic lock solution for patients with catheter-related bloodstream infections. The company believes all 92 events required to complete the trial have been achieved, pending confirmation from an independent review committee. The trial is being conducted in the U.S. and India, with several patients still in active treatment.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:44 pm

BFRI

Biofrontera Inc. (NASDAQ:BFRI) has completed patient enrollment for its Phase 3 clinical study evaluating Ameluz-PDT in combination with the BF-RhodoLED lamp for the treatment of basal cell carcinoma (BCC). The study is a significant step in the company's strategy to expand the Ameluz label beyond actinic keratosis (AK). The results of the study are expected in mid-2024.

Portfolio Pulse from Happy Mohamed

August 10, 2023 | 12:41 pm

ABVC

ABVC BioPharma, Inc. (NASDAQ:ABVC) has regained compliance with Nasdaq's minimum bid price requirement. The company had previously received a notification for failing to maintain a minimum bid price of $1.00 over 30 consecutive business days. However, the closing bid price of the company's common stock was at $1.00 per share or greater from July 25 to August 7, 2023, bringing it back into compliance.

Portfolio Pulse from Happy Mohamed

August 10, 2023 | 12:37 pm

BWAQ

Vietnam Sunergy Cell Company Limited (TOYO Solar) and Blue World Acquisition Corporation (NASDAQ:BWAQ) have announced a definitive business combination agreement. Post the transaction, Blue World will merge into a wholly owned subsidiary of TOYO Solar's parent company, TOYO Co., Ltd, which will be the holding company of the combined entity and be listed on Nasdaq. The transaction has been approved by the directors and shareholders of both companies and is expected to close in H1 2024, subject to regulatory approvals.

Portfolio Pulse from Happy Mohamed

August 10, 2023 | 12:35 pm

SPY

The USA Core CPI (MoM) for July remained steady at 0.2%, in line with estimates and the previous month's figure.

Portfolio Pulse from Happy Mohamed

August 10, 2023 | 12:30 pm

DIA

IWM

QQQ

SPY

The Consumer Price Index (CPI) for July has come in at 3.2%, slightly below the estimated 3.3%.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:30 pm

SPY

The Consumer Price Index (CPI) for July has met expectations, coming in at 0.2% month over month, the same as the prior month.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:30 pm

ZIMV

ZimVie has announced that the FDA has approved its new Mobi-C implant. This approval could potentially lead to increased sales and revenue for the company.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:07 pm

AMRS

APP

CPRI

GRTX

AppLovin Corporation's shares rose by 22.6% in pre-market trading following better-than-expected Q2 results. Capri Holdings Limited's shares also rose by 26.8% as Tapestry is reportedly nearing a deal to buy the company. On the other hand, Amyris, Inc.'s shares fell by 56.2% after the company filed for bankruptcy, and Galera Therapeutics, Inc.'s shares fell by 81.7% after receiving a Complete Response Letter from the U.S. FDA.

Portfolio Pulse from Lisa Levin

August 10, 2023 | 12:06 pm

DXR

Daxor Corporation has announced the publication of a research letter related to a heart failure trial with its BVA-100 product. The details of the trial and its results have not been disclosed in the news.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:03 pm